NCT00632216 A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE4
NCT00631579 Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma Status COMPLETED Phase PHASE2
NCT00630175 Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia Status COMPLETED Phase PHASE3
NCT00630045 Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis Status UNKNOWN Phase PHASE3
NCT00629720 Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology Status COMPLETED Phase PHASE3
NCT00629551 An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00627471 Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2) Status TERMINATED Phase PHASE4
NCT00625664 Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer Status COMPLETED Phase PHASE3
NCT00622700 Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00622648 Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin Status COMPLETED Phase PHASE4
NCT00621049 Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC Status COMPLETED Phase PHASE2
NCT00620100 To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent Status TERMINATED Phase PHASE2
NCT00619957 Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis Status COMPLETED Phase PHASE3
NCT00617968 GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer Status COMPLETED Phase PHASE2
NCT00617344 Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US Status COMPLETED Phase PHASE2
NCT00616694 Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy Status COMPLETED Phase PHASE4
NCT00614250 Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea Status COMPLETED Phase PHASE2